|
Bis(2,2,6,6-tetramethyl-1-piperidinyloxy-4-yl) sebacate
|
雙(2,2,6,6-四甲基-4-哌啶基)癸二酸酯氮氧自由基（UV-10）
|
2516-92-9
|
|
Enclomiphene citrate
|
恩氯米芬檸檬酸鹽
|
7599-79-3
|
|
Vecuronium bromide impurity
|
維庫溴銨雜質(zhì)
|
18668-29-6
|
|
Clomiphene Citrate
|
枸櫞酸氯米芬
|
50-41-9
|
|
Rocuronium intermediate 7
|
羅庫溴銨第七部
|
119302-20-4
|
|
Rocuronium bromide impurity 65
|
羅庫溴銨雜質(zhì)65
|
103088-58-0
|
|
Tadalafil intermediate 1
|
他達拉非中間體1
|
171752-68-4
|
|
Docetaxel
|
多西他賽（無水）
|
114977-28-5
|
|
Mitoxantrone
|
米托蒽醌
|
65271-80-9
|
|
Testolone
|
Testolone (RAD140)
|
1182367-47-0
|
|
2-methyl-1H-indole
|
2-甲基-1H-吲哚
|
95-20-5
|
|
Pipecuronium bromide
|
哌庫溴銨
|
52212-02-9
|
|
Rocuronium impurity K
|
羅庫溴銨雜質(zhì)K
|
|
|
α-Tropine
|
α-托品醇
|
120-29-6
|
|
Rocuronium bromide
|
羅庫溴銨
|
119302-91-9
|
|
Tadalafil
|
他達那非
|
171596-29-5
|
|
Trans-2,6-Dimethylmorpholine
|
反式－2、6－二甲基嗎啉
|
6485-45-6
|
|
Cabozantinib Malate
|
蘋果酸卡博替尼
|
1140909-48-3
|
|
Ponesimod
|
珀奈莫德
|
854107-55-4
|
|
3-Tropanone; 8-Methyl-8-azabicyclo[3.2.1]octan-3-one
|
托品酮
|
532-24-1
|
|
Granisetron
|
格拉司瓊
|
109889-09-0
|
|
BI-4142
|
BI-4142
|
2682003-36-5
|
|
Vecuronium bromide impurity C
|
維庫溴銨雜質(zhì)c
|
73319-30-9
|
|
Irbinitinib
|
妥卡替尼
|
937263-43-9
|
|
Paclitaxel
|
紫杉醇
|
33069-62-4
|
|
Toremifene Citrate
|
枸櫞酸托瑞米芬
|
89778-27-8
|
|
3H-Imidazo[1,2-a]pyrrolo[2,3-e]pyrazine, 8-[(3R,4S)-4-ethyl-3-pyrrolidinyl]-, hydrochloride (1:2)
|
烏帕替尼N-1
|
2050038-84-9
|
|
Vecuronium
|
維庫
|
50700-72-6
|
|
Selpercatinib
|
塞爾帕替尼
|
2152628-33-4
|
|
Docetaxel
|
多西他賽(三水)
|
148408-66-6
|
|
|
β-托品醇
|
135-97-7
|
|
Maropitant Citrate
|
枸櫞酸馬羅匹坦
|
359875-09-5
|
|
Rocuronium bromide intermediate 47
|
羅庫溴銨雜質(zhì)47
|
|
|
Mitoxantrone dihydrochloride
|
鹽酸米托蒽醌
|
70476-82-3
|
|
Vecuronium bromide impurity F
|
維庫溴銨雜質(zhì)F
|
73319-13-8
|
|
Cabazitaxel
|
卡巴他賽
|
183133-96-2
|
|
Cabazitaxel intermediate
|
7,10二甲氧基10-DAB (卡巴他賽中間體)
|
183133-94-0
|
|
Brigatinib
|
布格替尼
|
1197953-54-0
|
|
Natamycin,PIMARICIN;Synogil;natacyn;
|
那他霉素
|
7681-93-8
|
|
|
化合物A86新品
|
2079069-01-3
|
|
Gliclazide
|
格列齊特
|
21187-98-4
|
|
Tadalafil intermediate 2
|
他達拉非中間體2
|
171489-59-1
|
|
Zongertinib
|
宗爾替尼
|
2728667-27-2
|
|
Vecuronium bromide impurity B
|
維庫溴銨雜質(zhì)B
|
50587-95-6
|
|
4-benzylidene-2,6-ditert-butylcyclohexa-2,5-dien-1-one
|
4-苯基亞甲基-2,6-二叔丁基-2,5-環(huán)己二烯-1-酮
|
7078-98-0
|
|
APR-246
|
PRIMA-1Met
|
5291-32-7
|
|
Zorifertinib
|
佐利替尼
|
1626387-80-1
|
|
Upadacitinib
|
烏帕替尼
|
1310726-60-3
|
|
Sunvozertinib
|
舒沃替尼
|
2370013-49-1
|
|
Rocuronium intermediate 8
|
羅庫溴銨第八部
|
119302-24-8
|
|
Rocuronium impurity H
|
羅庫溴銨雜質(zhì)H
|
1190105-67-9
|
|
Rocuronium impurity E
|
羅庫溴銨雜質(zhì)E
|
1190105-65-7
|
|
Cyclohexyl(phenyl)methanol
|
環(huán)己基(苯基)甲醇
|
945-49-3
|
|
TAS6417
|
TAS6417
|
1661854-97-2
|
|
Rocuronium bromide Intermediate
|
羅庫溴銨雜質(zhì)
|
14935-81-0
|
|
Vecuronium intermediate 6
|
維庫溴銨第六部
|
13522-16-2
|
|
Taletrectinib
|
他立替尼
|
1505515-69-4
|
|
Tuxobertinib (BDTX-189)
|
|
2414572-47-5
|
|
tadalafi
|
他達拉非
|
|
|
Pancuronium bromide
|
泮庫溴銨
|
15500-66-0
|
|
cabozantinib
|
卡博替尼
|
849217-68-1
|
|
Mobocertinib
|
莫博替尼
|
1847461-43-1
|
|
Mobocertinib succinate
|
琥珀酸莫博替尼
|
2389149-74-8
|
|
BLU-451(LNG451)
|
BLU-451(LNG451)
|
2769954-39-2
|
|
2-Methylindoline
|
2-甲基吲哚啉
|
6872-06-6
|
|
Cis-2,6-Dimethylmorpholine
|
順式－2、6－二甲基嗎啉
|
6485-55-8
|
|
Rocuronium impurity D
|
羅庫溴銨雜質(zhì)D
|
1190105-63-5
|
|
3-(p-Methoxyphenyl)-1,2,3,4-tetrahydronaphthalen-1-one
|
3-(4-甲氧基苯基)-1(2H)-萘酮
|
61696-79-5
|
|
BMS-986165(Deucravacitinib)
|
|
2866415-98-5
|
|
3-AZABICYCLO[3.3.0]OCTANE HYDROCHLORIDE
|
3-氮雜雙環(huán)[3.3.0]辛烷鹽酸鹽
|
112626-50-3
|
|
2-Methoxy-5-nitrophenol sodium salt
|
5-硝基愈創(chuàng)木酚鈉
|
67233-85-6
|
|
Benzeneazomalononitrile
|
苯基偶氮丙二腈
|
6017-21-6
|
|
Rocuronium bromide intermediate
|
羅庫溴銨雜質(zhì)
|
159325-45-8
|
|
Granisetron Hydrochloride
|
鹽酸格拉司瓊
|
107007-99-8
|